Loading…
Lobbying Spend
—
Filings
40
Firms Hired
2
Active Period
2017–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
SUPPORT for Patients and Communities Reauthorization Act of 2025
2026 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2026 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
SAFE Drugs Act of 2026
2026 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 3794
SUPPORT for Patients and Communities Reauthorization Act of 2025
2026 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2026 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $20,000
Matched citations: HR 929
SAFE Drugs Act of 2026
2026 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Client expense: — · Firm income: $20,000
Matched citations: S. 3794
SUPPORT for Patients and Communities Reauthorization Act of 2025
2026 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2026 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
SAFE Drugs Act of 2026
2026 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 3794
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · fourth_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · fourth_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · fourth_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · fourth_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $20,000
Matched citations: HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · third_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $20,000
Matched citations: HR 929
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · second_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
2025 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2483
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
2025 · first_quarter · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 929
Source: Senate LDA